These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37794898)

  • 41. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
    Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
    Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Relationship between blood uric acid levels and body composition in patients with polycystic ovary syndrome].
    Li X; Zhang JF; Feng YR; Tang QT; Kuai D; Tian WY; Zhang HY
    Zhonghua Fu Chan Ke Za Zhi; 2023 Jul; 58(7):508-515. PubMed ID: 37474324
    [No Abstract]   [Full Text] [Related]  

  • 43. Evaluation of Triglyceride Glucose Index and Homeostasis Model of Insulin Resistance in Patients with Polycystic Ovary Syndrome.
    Zheng Y; Yin G; Chen F; Lin L; Chen Y
    Int J Womens Health; 2022; 14():1821-1829. PubMed ID: 36582617
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Degree of Menstrual Disturbance Is Associated With the Severity of Insulin Resistance in PCOS.
    Li X; Yang D; Pan P; Azziz R; Yang D; Cheng Y; Zhao X
    Front Endocrinol (Lausanne); 2022; 13():873726. PubMed ID: 35769085
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum AMH levels and insulin resistance in women with PCOS.
    Sahmay S; Aydogan Mathyk B; Sofiyeva N; Atakul N; Azemi A; Erel T
    Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():159-164. PubMed ID: 29605710
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of leptin and insulin resistance in PCOS: A case-controlled study.
    Namavar Jahromi B; Dabaghmanesh MH; Parsanezhad ME; Fatehpoor F
    Int J Reprod Biomed; 2017 Jul; 15(7):423-428. PubMed ID: 29177243
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?
    Skałba P; Cygal A; Madej P; Dąbkowska-Huć A; Sikora J; Martirosian G; Romanik M; Olszanecka-Glinianowicz M
    Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):254-9. PubMed ID: 21752527
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of oxytocin level, glucose metabolism components and cutoff values for oxytocin and anti-mullerian hormone in infertile PCOS women.
    Jahromi BN; Dabbaghmanesh MH; Bakhshaie P; Parsanezhad ME; Anvar Z; Alborzi M; Zarei A; Bakhshaei M
    Taiwan J Obstet Gynecol; 2018 Aug; 57(4):555-559. PubMed ID: 30122578
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum Uric Acid Levels and Metabolic Indices in an Obese Population: A Cross-Sectional Study.
    Li F; Chen S; Qiu X; Wu J; Tan M; Wang M
    Diabetes Metab Syndr Obes; 2021; 14():627-635. PubMed ID: 33603427
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome.
    Wehr E; Pilz S; Schweighofer N; Giuliani A; Kopera D; Pieber TR; Obermayer-Pietsch B
    Eur J Endocrinol; 2009 Oct; 161(4):575-82. PubMed ID: 19628650
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
    Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M
    Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Monocyte chemoattractant protein-1 and its correlation with lipoprotein in polycystic ovary syndrome].
    Hu WH; Qiao J; Zhao SY; Zhang XW; Li MZ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):487-91. PubMed ID: 17068620
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insulin resistance and adverse metabolic profile in overweight/obese and normal weight of young women with polycystic ovary syndrome.
    Gholinezhad M; Gholsorkhtabaramiri M; Esmaeilzadeh S; Ghanbarpour A
    Caspian J Intern Med; 2018; 9(3):260-267. PubMed ID: 30197771
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Activity and distribution of plasma platelet-activating factor acetylhydrolase in polycystic ovary syndrome patients with insulin resistance].
    Wan DH; Fan P; Bai H; Song Q; Liu HW
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):30-4. PubMed ID: 20367923
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum uric acid/creatinine ratio and free androgen index are synergistically associated with increased risk of polycystic ovary syndrome in obese women.
    El-Eshmawy MM; Ibrahim A; Bahriz R; Shams-Eldin N; Mahsoub N
    BMC Endocr Disord; 2022 Dec; 22(1):315. PubMed ID: 36514085
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?
    Yang S; Wang Q; Huang W; Song Y; Feng G; Zhou L; Tan J
    Gynecol Endocrinol; 2016; 32(1):38-41. PubMed ID: 26291816
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome.
    Anik Ilhan G; Yildizhan B; Pekin T
    Gynecol Endocrinol; 2019 Mar; 35(3):233-236. PubMed ID: 30303693
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adiponectin in women with polycystic ovary syndrome.
    Shin HY; Lee DC; Lee JW
    Korean J Fam Med; 2011 May; 32(4):243-8. PubMed ID: 22745860
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolic dysfunction in obese Hispanic women with polycystic ovary syndrome.
    Sam S; Scoccia B; Yalamanchi S; Mazzone T
    Hum Reprod; 2015 Jun; 30(6):1358-64. PubMed ID: 25857311
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intrinsic factors rather than vitamin D deficiency are related to insulin resistance in lean women with polycystic ovary syndrome.
    Sahin S; Eroglu M; Selcuk S; Turkgeldi L; Kozali S; Davutoglu S; Muhcu M
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2851-6. PubMed ID: 25339479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.